期刊文献+

骶管阻滞复合瑞芬太尼静脉输注在小儿麻醉中的应用 被引量:2

原文传递
导出
摘要 目的探讨骶管阻滞复合瑞芬太尼静脉输注用于小儿麻醉的临床效果和安全性。方法60例择期行泌尿外科手术的小儿随机分成2组,骶管阻滞复合瑞芬太尼组(A组)和氯胺酮组(B组),两组各30例。A组应用骶管阻滞复合瑞芬太尼静脉输注麻醉,B组应用氯胺酮静脉输注全身麻醉。于麻醉诱导前、麻醉后5min、切皮时、术中15min、术毕记录其平均动脉压、心率、呼吸频率、血氧饱和度,并比较两组苏醒时间及术后早期恢复情况。结果A组术中呼吸循环状态较B组稳定。A组麻醉苏醒时间为(II.25±4.45)min,B组为(52.80±8.64)min,A组明显短于B组(P〈0.01)。B组术后早期恢复情况较A组差。结论骶管阻滞复合瑞芬太尼静脉输注用于小儿泌尿外科手术,可保证呼吸、循环稳定,是一种较为理想的麻醉方法。
出处 《中国小儿急救医学》 CAS 2009年第2期192-193,共2页 Chinese Pediatric Emergency Medicine
  • 相关文献

参考文献7

二级参考文献28

  • 1曾慎健.艾司洛尔的临床应用[J].新药与临床,1989,8(3):152-154. 被引量:3
  • 2Glass P S,Anesth Analg,1999年,89卷,S7页
  • 3Kan R E,Anesthesiology,1998年,88卷,1467页
  • 4曹慎健,新药与临床,1989年,8卷,152页
  • 5Davis PJ, Ross AK, Stiller RL, et al. Pharmacokinetics of remifentanil in anesthetized children 2-12 years of age. Anesth Analg, 1995,80:S93.
  • 6Burkle H, Dunbar S, Van Aken H. Remifentanil: a novel, short-acting,mu-opioid. Anesth Analg, 1996,83: 646-651.
  • 7Glass PS, Hardman D, Kamiyama Y, et al. Preliminary pharmacokinetics and pharmacodynamics of an ultra-short-acting opioid: remifentanil (GI87084B). Anesth Analg, 1993,77:1031-1040.
  • 8Ross AK, Davis PJ, Dear GDEL, et al. Pharmcokinetics of remifentanil in anesthetized pediatric patients undergoing elective surgery or diagnostic procedures. Anesth Analg,2001,93:1393-1401.
  • 9John BE, Anne ML. Use of remifentanil in infants. Paediatric Anaesthesia, 1998,8:437-439.
  • 10Bovill JG, Sebel PS. Pharmacokinetics of high-dose fentanyl. A study in patients undergoing cardiac surgery. Br J Anaesth, 1980,52:795-801.

共引文献951

同被引文献32

  • 1薛刚,吴立新.舌扁桃体肥大45例诊治体会[J].河北医药,1996,18(3):137-138. 被引量:4
  • 2陈宏志,李璐,陈卫民.瑞芬太尼复合丙泊酚麻醉在小儿气管异物取出术中的应用[J].中国小儿急救医学,2007,14(3):218-220. 被引量:28
  • 3Martijn R,Kruijt S,Nicolaas A,et al.Pharmacology in the elderly and newer anaesthesia drugs[J].Best Practice & Research Clinical Anaesthesiology,2011,25(3):355-365.
  • 4Soo JP,Shim YH,Ji HY,et al.Low-dose remifentanil to modify hemodynamic responses to tracheal intubation:comparison in normotensive and untreated/treated hypertensive Korean patients[J].Korean J Anesthesiol,2012,62(2):135-141.
  • 5Rhee YS,Park CW,Tackoon O,et al.Effect of electrokinetic stabilizers on the physicochemical properties of propofol emulsions[J].International Journal of Pharmaceutics,2010,398(2):21-24.
  • 6Graham A,Neilson MB,Ch B.Sedation and anesthesia for interventional oncology[J].Seminars in Roentgenology,2007,42(3):154-155.
  • 7Steven E,Guoming X,Julia L,et al.A response surface analysis of propofol-remifentanil pharmacodynamic interaction in volunteers[J].Anesthesiology,2004,100(6):1373-1381.
  • 8Iain G.Pharmacokinetic analysis[J].Pharmacology,2005,6(8):280-282.
  • 9Richebé P,Pouquet O,Jelacic S,et al.Target-controlled dosing of remifentanil during cardiac surgery reduces postoperative hyperalgesia[J].J Cardiothorac Vasc Anesth,2011,25(6):917-925.
  • 10Jeong JL,Gun HK,Jie AK,et al.Comparison of pulmonary morbidity using sevoflurane or propofol-remifentanil anesthesia in anivor lewis operation[J].Journal of Cardiothoracic and Vascular Anesthesia,2012,26(5):857-862.

引证文献2

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部